Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04178967 |
|---|---|
| Brief Title: | Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate2) |
| First Submitted : | November 25, 2019 |
| First Submitted that Met QC Criteria : | November 25, 2019 |
| First Posted : | November 26, 2019 |
| Results First Submitted : | July 11, 2022 |
| Results First Posted with QC Comments : | August 8, 2022 |
| Results First Submitted that Met QC Criteria : | August 22, 2022 |
| Results First Posted : | September 16, 2022 |
| Last Update Submitted that Met QC Criteria : | August 22, 2022 |
| Last Update Posted : | September 16, 2022 |